Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning

作者: Ken-ichi Kinoshita , Yayoi Tada , Yoshikage Muroi , Toshihiro Unno , Toshiaki Ishii

DOI: 10.1016/J.LFS.2015.07.017

关键词:

摘要: Abstract Aims Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNpc). In PD, thinking and retrieval deficits often arise from cognitive impairments. However, mechanism disorders PD remains unknown. Therefore, we investigated function model mice produced intraperitoneal administration 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which specifically destroys DAergic SNpc. Main methods We evaluated MPTP-treated (PD mice) using contextual fear conditioning test. test, each experiment consists three phases: training, re-exposure, testing. Mice were trained with foot shock (a weak unconditioned stimulus: 1 mA/2 s duration, once, or an intense 2 mA/2 s twice), 24 h later, re-exposed to training context for 3 min determine reconsolidation 30 min extinction. The percentage time spent freezing was measured during test session as indexes memory consolidation, reconsolidation, Key findings Reconsolidation occurred normally but extinction facilitated compared control mice. Moreover, retention attenuated earlier than controls following repeated conditioned stimuli every day. Significance selective SNpc showed retention, probably via learning.

参考文章(40)
Michael W. Jakowec, Giselle M. Petzinger, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates. Comparative Medicine. ,vol. 54, pp. 497- 513 ,(2004)
Serge Przedborski, Vernice Jackson-Lewis, Ali B. Naini, Michael Jakowec, Giselle Petzinger, Reginald Miller, Muhammad Akram, The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety Journal of Neurochemistry. ,vol. 76, pp. 1265- 1274 ,(2001) , 10.1046/J.1471-4159.2001.00183.X
Xiaoyu Sun, Zhongkui Xiong, Yongfang Zhang, Ya Meng, Gang Xu, Zhiming Xia, Jiamei Li, Rui Zhang, Zunji Ke, Zongqin Xia, Yaer Hu, Harpagoside attenuates MPTP/MPP+ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor Journal of Neurochemistry. ,vol. 120, pp. no- no ,(2012) , 10.1111/J.1471-4159.2011.07635.X
Karim Nader, Glenn E. Schafe, Joseph E. Le Doux, Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval Nature. ,vol. 406, pp. 722- 726 ,(2000) , 10.1038/35021052
Olena Bukalo, Courtney R Pinard, Andrew Holmes, Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders British Journal of Pharmacology. ,vol. 171, pp. 4690- 4718 ,(2014) , 10.1111/BPH.12779
Stephen Maren, Gregory J. Quirk, Neuronal signalling of fear memory Nature Reviews Neuroscience. ,vol. 5, pp. 844- 852 ,(2004) , 10.1038/NRN1535
K Ray Chaudhuri, Daniel G Healy, Anthony HV Schapira, Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurology. ,vol. 5, pp. 235- 245 ,(2006) , 10.1016/S1474-4422(06)70373-8
Marta G. Vučković, Ruth I. Wood, Daniel P. Holschneider, Avery Abernathy, Daniel M. Togasaki, Alexandra Smith, Giselle M. Petzinger, Michael W. Jakowec, Memory, Mood, Dopamine, and Serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Mouse Model of Basal Ganglia Injury Neurobiology of Disease. ,vol. 32, pp. 319- 327 ,(2008) , 10.1016/J.NBD.2008.07.015